Hutcheson, J.; Conway, D.; Kumar, S.; Wiseman, C.; Chakraborty, S.; Skrypkin, E.; Horan, M.; Gunning, A.; Williams, C.K.; Kuperwasser, C.;
et al. Analytical Validation of NavDx+Gyn, a cfDNA-Based Fragmentomic Profiling Assay for HPV-Driven Gynecologic Cancers. Diagnostics 2025, 15, 825.
https://doi.org/10.3390/diagnostics15070825
AMA Style
Hutcheson J, Conway D, Kumar S, Wiseman C, Chakraborty S, Skrypkin E, Horan M, Gunning A, Williams CK, Kuperwasser C,
et al. Analytical Validation of NavDx+Gyn, a cfDNA-Based Fragmentomic Profiling Assay for HPV-Driven Gynecologic Cancers. Diagnostics. 2025; 15(7):825.
https://doi.org/10.3390/diagnostics15070825
Chicago/Turabian Style
Hutcheson, Joshua, David Conway, Sunil Kumar, Chloe Wiseman, Syandan Chakraborty, Evgeny Skrypkin, Michael Horan, Alicia Gunning, Cassin Kimmel Williams, Charlotte Kuperwasser,
and et al. 2025. "Analytical Validation of NavDx+Gyn, a cfDNA-Based Fragmentomic Profiling Assay for HPV-Driven Gynecologic Cancers" Diagnostics 15, no. 7: 825.
https://doi.org/10.3390/diagnostics15070825
APA Style
Hutcheson, J., Conway, D., Kumar, S., Wiseman, C., Chakraborty, S., Skrypkin, E., Horan, M., Gunning, A., Williams, C. K., Kuperwasser, C., Naber, S. P., & Gupta, P. B.
(2025). Analytical Validation of NavDx+Gyn, a cfDNA-Based Fragmentomic Profiling Assay for HPV-Driven Gynecologic Cancers. Diagnostics, 15(7), 825.
https://doi.org/10.3390/diagnostics15070825